ResMed

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ResMed and other ETFs, options, and stocks.

About RMD

ResMed, Inc. engages in providing digital health and cloud-connected medical devices. Its digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, chronic obstructive pulmonary disease, or COPD, and other chronic diseases. 

CEO
Michael J. Farrell
CEOMichael J. Farrell
Employees
10,600
Employees10,600
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
1989
Founded1989
Employees
10,600
Employees10,600

RMD Key Statistics

Market cap
37.71B
Market cap37.71B
Price-Earnings ratio
25.53
Price-Earnings ratio25.53
Dividend yield
0.87%
Dividend yield0.87%
Average volume
1.17M
Average volume1.17M
High today
$271.05
High today$271.05
Low today
$245.21
Low today$245.21
Open price
$255.23
Open price$255.23
Volume
2.26M
Volume2.26M
52 Week high
$293.81
52 Week high$293.81
52 Week low
$199.92
52 Week low$199.92

Stock Snapshot

With a market cap of 37.71B, ResMed(RMD) trades at $258.31. The stock has a price-to-earnings ratio of 25.53 and currently yields dividends of 87.5%.

During the trading session on 2026-02-01, ResMed(RMD) shares reached a daily high of $271.05 and a low of $245.21. At a current price of $258.31, the stock is +5.3% higher than the low and still -4.7% under the high.

Trading volume for ResMed(RMD) stock has reached 2.26M, versus its average volume of 1.17M.

The stock's 52-week range extends from a low of $199.92 to a high of $293.81.

The stock's 52-week range extends from a low of $199.92 to a high of $293.81.

RMD News

TipRanks 1d
ResMed Reaffirms 2025 Risk Profile: No Material Changes to Previously Disclosed Threats

Resmed Inc (RMD) has disclosed a new risk, in the Regulation category. Resmed Inc. continues to face the same material risks and uncertainties previously discl...

TipRanks 1d
ResMed Inc Earnings Call Shows Profitable Growth Momentum

Resmed Inc ((RMD)) has held its Q2 earnings call. Read on for the main highlights of the call. Claim 50% Off TipRanks Premium Unlock hedge fund-level data and p...

Benzinga 2d
Analysts Maintain Bull Case On ResMed Despite Competition Concerns

On Thursday, ResMed Inc (NYSE:RMD) reported that second-quarter fiscal 2026 adjusted earnings of 2.81, beating the consensus of $2.72. Quarterly sales increase...

Analysts Maintain Bull Case On ResMed Despite Competition Concerns

Analyst ratings

69%

of 29 ratings
Buy
69%
Hold
27.6%
Sell
3.4%

More RMD News

TipRanks 2d
ResMed price target raised to $314 from $311 at RBC Capital

RBC Capital analyst Craig Wong-Pan raised the firm’s price target on ResMed (RMD) to $314 from $311 and keeps an Outperform rating on the shares. The company de...

Simply Wall St 2d
ResMed Founder’s Horatio Alger Honor And What It Means For Investors

ResMed (NYSE:RMD) founder Dr. Peter Farrell is set to receive the Horatio Alger Award for lifetime achievement. The award recognizes his role in building ResMe...

ResMed Founder’s Horatio Alger Honor And What It Means For Investors
The Motley Fool 2d
ResMed Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. Thursday, January 29, 2026 at 4:30 p.m. ET Call participants Chief Executive Officer — Mick Farrell Chief Financial Officer — Br...

ResMed Q2 2026 Earnings Call Transcript
TipRanks 2d
ResMed Announces Dividend and Strong Quarterly Earnings Growth

Resmed ( (RMD) ) has provided an update. On January 29, 2026, Resmed’s board declared a quarterly cash dividend of US$0.60 per share, payable March 19, 2026, t...

Simply Wall St 7d
A Look At ResMed Valuation As Investors Await December 2025 Earnings Report

Advertisement Upcoming earnings as the key near term catalyst ResMed (RMD) heads into its upcoming December 2025 quarter earnings report on January 29 with ma...

A Look At ResMed Valuation As Investors Await December 2025 Earnings Report

People also own

Based on the portfolios of people who own RMD. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.